Israel - English - Ministry of Health

teva pharmaceutical industries ltd, israel - tamsulosin hydrochloride - modified release capsules - tamsulosin hydrochloride 0.4 mg - tamsulosin - tamsulosin - treatment of functional symptoms of benign prostatic hyperplasia (bph).

Israel - English - Ministry of Health

unipharm ltd, israel - tinidazole - tablets - tinidazole 500 mg - tinidazole - tinidazole - for the oral treatment of trichomonas vaginals infections of the genito urinary tract in both female and male. for the prevention of anerobic infections after gynocological operations and stomach operations.

Israel - English - Ministry of Health

abic marketing ltd, israel - bosentan as monohydrate - film coated tablets - bosentan as monohydrate 125 mg - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease.

Israel - English - Ministry of Health

abic marketing ltd, israel - bosentan as monohydrate - film coated tablets - bosentan as monohydrate 62.5 mg - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease.

Israel - English - Ministry of Health

bayer israel ltd - levonorgestrel - film coated tablets - levonorgestrel 0.03 mg - levonorgestrel - oral contraception.

Israel - English - Ministry of Health

teva israel ltd - fulvestrant - solution for injection - fulvestrant 50 mg/ml - fulvestrant - monotherapyfulvestrant teva is indicated for the treatment of oestrogen receptor positive, locally advanced or metastatic breast cancer in postmenopausal women:* not previously treated with endocrine therapy,or* with disease relapse on or after adjuvant endocrine therapy, or* with disease progression on endocrine therapy.combination therapyfulvestrant teva is indicated for the treatment of:- hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in men and postmenopausal women in combination with ribociclib as initial endocrine based therapy or following disease progression on endocrine therapy.- hr- positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with palbociclib or abemaciclib in women with disease progression after endocrine therapy.

Israel - English - Ministry of Health

novartis israel ltd - brolucizumab - solution for injection - brolucizumab 120 mg / 1 ml - brolucizumab - beovu is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (amd).

Israel - English - Ministry of Health

cts chemical industries ltd, israel - dicyclomine hydrochloride - tablets - dicyclomine hydrochloride 10 mg - dicycloverine - dicycloverine - adjunctive therapy in irritable bowel syndrome, neurogenic bowel disturbance.

Israel - English - Ministry of Health

rafa laboratories ltd - acarbose - tablets - acarbose 50 mg - acarbose - acarbose - treatment of non-insulin dependent diabetes mellitus (niddm) in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.

Israel - English - Ministry of Health

rafa laboratories ltd - acarbose - tablets - acarbose 100 mg - acarbose - acarbose - treatment of non-insulin dependent diabetes mellitus (niddm) in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.